Mepron and Forteo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mepron (atovaquone) and Forteo (teriparatide recombinant human). Common drug interactions include appendicitis among females.

The phase IV clinical study analyzes what interactions people have when they take Mepron and Forteo. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Mepron?

Mepron has active ingredients of atovaquone. It is often used in babesiosis. eHealthMe is studying from 2,091 Mepron users. Check the latest studies of Mepron.

What is Forteo?

Forteo has active ingredients of teriparatide recombinant human. It is often used in osteoporosis. eHealthMe is studying from 127,076 Forteo users. Check the latest studies of Forteo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

31 people who take Mepron and Forteo together, and have interactions are studied.

What are the common drug interactions of Mepron and Forteo, by gender? *:

female:

Appendicitis (inflammation of the appendix)
Aptyalism (deficiency or absence of saliva)
Dental caries
Diarrhoea
Enteritis (inflammation of the small intestine)
Enterococcal infection
Escherichia infection (bacterial infection by escherichia coli)
Essential thrombocythaemia (chronic blood cancer)
Exostosis (formation of new bone on the surface of a bone)
Facial neuralgia (pain of face)

male:

n/a

What are the common drug interactions of Mepron and Forteo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Hyperglycaemia (high blood sugar)
Foot deformity (functional disability of foot)
Otitis externa (external ear infection)
Anxiety
Weight decreased
Cor pulmonale chronic (long lasting enlargement of the right ventricle of the heart)
Gastroduodenitis (an inflammation of the mucous membrane of the stomach and duodenum)
Nausea (feeling of having an urge to vomit)
Uterine enlargement
Cardiac failure congestive

60+:

Adverse drug reaction
Burning sensation
Peripheral swelling
Pruritus (severe itching of the skin)
Rash
Tinnitus (a ringing in the ears)
Death
Eyelid disorder
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Herpes zoster

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 28 people, 90.32%
Thrombocytopenia (decrease of platelets in blood): 11 people, 35.48%

* Approximation only. Some reports may have incomplete information.

Do you take Mepron and Forteo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously